CLINICAL_TRIALS
research
· 2026-02-10
Clinical Trial Update: Artificial-Intelligence-based Early Detection of Diabetic Retinopathy (FUNDUS AI)
Summary
An ongoing University Hospital Tuebingen trial is evaluating FUNDUS AI, an artificial intelligence tool for early detection of diabetic retinopathy in people wi…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University Hospital Tuebingen | Conditions: Diabetes (DM), Prediabetes | Status: ENROLLING_BY_INVITATION